v3.26.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 1,195 $ 2,189
General and administrative 1,331 1,205
Total operating expenses 2,526 3,394
Loss from operations (2,526) (3,394)
Other income (expense):    
Interest income 94 15
Other (expense) income, net (2) 32
Net loss $ (2,434) $ (3,347)
Loss per share, basic (in dollars per share) $ (0.96) $ (5.51)
Loss per share, diluted (in dollars per share) $ (0.96) $ (5.51)
Weighted average number of shares of common stock, basic (in shares) 2,533,918 606,928
Weighted average number of shares of common stock, diluted (in shares) 2,533,918 606,928

Source